Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Awards $42.3M in Grand Opportunities Grants

NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences announced yesterday that it has awarded $42.3 million in Grand Opportunities grants to 14 research teams, most of which will use their awards to develop 'omics technologies.

The grants are being funded through the American Recovery and Reinvestment Act, and they support projects at more than 20 research institutions and organizations in 13 states.

The Grand Opportunities program was developed by the National Institutes of Health to stimulate biomedical research projects "that promise to have a significant impact on a field of biomedical science over two years," NIGMS Director Jeremy Berg said in a statement.

Project titles, funding amounts, principal investigators, and institutions receiving GO grants from NIGMS include:

• VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment; $1.4 million. PIs: Daniel Masys and Dan Roden, Vanderbilt University Medical Center in Nashville, Tenn.

• Gene Expression and Regulatory Networks in Human Leukocytes; $7.3 million. PIs: Christophe Benoist and Diane Mathis, Harvard Medical School, Boston.

• ImageJ as an Extensible Image-Processing Framework; $1.8 million. PI: Kevin Eliceiri, University of Wisconsin-Madison.

• Metabolomics Network for Drug Response Phenotype; $4.5 million. PIs: Rima Kaddurah-Daouk, Duke University Medical Center, Durham, NC.

• The Arabidopsis Transcription Factor ORFeome and Downstream Genomic Application; $2 million. PIs: Steve Kay, University of California, San Diego, and Joseph Ecker, Salk Institute for Biological Studies, La Jolla, Calif.

• A Multi-disciplinary Approach to Elucidating Gene Function in a Model Gram-Positive Bacterium; $2 million. PI: David Rudner, Harvard Medical School.

• SciBay: A New Methodology for Scientific Collaboration and Gene Function Determination; $4 million. PIs: Martin Steffen and Simon Kasif, Boston University School of Medicine, and Richard Roberts, New England BioLabs, Ipswich, Mass.

• Innovative Supercomputing for Breakthrough Molecular Dynamics; $2.7 million. PI: Joel Stiles, Carnegie Mellon University, Pittsburgh.

A full list of grant recipients and project descriptions can be found here.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.